priority health glp-1 coverage Nutritional priorities to support GLP‐1 therapy for obesity: A joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society GLP-1 insurance coverage worsened at

The SELECT trial, published in 2023, enrolled 17,604 adults with overweight or obesity and established cardiovascular disease but without diabetes

This suggests that GLP-1 receptor agonists may confer cardiovascular protection through multiple mechanisms, potentially including anti-inflammatory effects, blood pressure reduction, and vascular benefits, in addition to lipid improvements

For clinicians, the trial could inform new care pathways involving baseline DEXA, mobility assessments, and long-term monitoring

MyFair Cream MyFair Cream is a freckle whitening cream that helps reduce pigmentation, dark spots, and uneven skin tone by promoting skin renewal and controlling melanin production